Brain Tumor Related News!
Fundraisers For Brain Tumor Research!
Brain Tumor Conferences / Events
New Clinical Trials
Noteworthy Treatments Explanation of the new high tech treatments!
Conferences / Events
Outsmarting Brain Tumors: A Conference on Brain Tumors for Patients, Families and Caregivers - September 23,2017 at Cedars-Sinai Medical Center in Los Angeles, CA
The multi-disciplinary faculty of the Department of Neurosurgery offers this conference to bring participants up to date on the most recent advances in the diagnosis and treatment of adult brain tumors. This free conference seeks to educate patients and their caregivers on the latest research that has been translated into treatments for brain tumors.
Miramonte Indian wells Resort and Spa
45000 Indian Wells Lane
Indian Wells, CA 92210
Self-Parking is Complimentary
To register, please call 1-800-CEDARS-1 (1-800-233-2771) or online at www.cedars-sinai.edu/neuroconferences
Brain Tumor News!
Displaying Stories 1 to 20 of 6,206
07/23/17 Glioblastoma: New tools against brain cancer
This is one of my favorite new treatments. It is too early to tell how well it works, but it looks promising. Disclaimer: I am on the patient advisory board at the Brain Tumor Center at Duke (but have no financial involvement in this treatment)
07/19/17 Human CAR-T Cell Glioblastoma Trial Generates Clues for Improving Treatment
This was too small to tell if the treatment works, but it did prove that these cells can cross the blood brain barrier- which is a major step forward. CAR-T cell therapy is one of the most exciting new therapies available. Recently the first CAR-T cell therapy for leukemia was approved by the FDA, after trials showing very high long term remission rates after a single injection!
07/06/17 Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme.
Comparative Study of Adjuvant Temozolomide Six Cycles Versus Extended 12 Cycles in Newly Diagnosed Glioblastoma Multiforme. 6 months of Temozolomide for newly diagnosed patients became the standard because the original trials specified 6 months. That was done to speed up the trials. They didn't try various lengths of time and picked the best. This study looks at using 6 vs 12 months or Temozolomide. It is a small study - so you have to be careful, but using the 12 months of temozolomide increased overall survival by over 50% but did triple the chances of having toxicity.
07/06/17 Optimizing bevacizumab dosing in glioblastoma: less is more.
The "standard" dosage of Avastin for brain tumors was not determined by a trial. Other cancers used 10mg/kg. The original small trials for brain tumors used 5mg/kg because of a worry about causing bleeding in the brain - which didn't happen, and it worked well. Then when larger brain tumor trials started up they went with the standard 10mg/kg dose other cancers use. Some brain tumor doctors still use the 5mg/kg lower dose and feel it works as well or better with less side effects. This study goes a step further and says less than 3mg may work as well or better with much less side effects. May be worth considering. They had a big increase in survival but there weren't enough patients to say that is significant statistically
07/06/17 Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice. Gliadel wafer is a biodegradable implant that slowly releases chemotherapy at the tumor site. It was approved on 1995 and it's popularity has waned. One of the main reasons is that many clinical trials said that using Gliadel wafer makes you ineligible for the trials. Some major brain tumor centers use this routinely on everyone who has a glioblastoma surgery, and others almost never use it. It is worth asking your surgeon about. This report shows that it is associated with longer progression free survival and overall survival.
Displaying Stories 1 to 20 of 6206